Platform Trial Designs in Drug Development (PDF)
Drug development sponsors cannot run individual trials for all products in all indications. This results in missed opportunities. Clinical trial programs known as "basket" and "umbrella" have demonstrated that multi-product, multi-indication trials can be efficient and feasible.
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Drug development sponsors cannot run individual trials for all products in all indications. This results in missed opportunities. Clinical trial programs known as "basket" and "umbrella" have demonstrated that multi-product, multi-indication trials can be efficient and feasible.
Robert Beckman is Professor of Oncology and of Biostatistics, Bioinformatics, and Biomathematics at the Lombardi Comprehensive Cancer Center and the Innovation Center of Biomedical Informatics, Georgetown University Medical Center. He has played significant leadership roles in developing new oncology clinical research groups at four pharmaceutical companies, while co-inventing several novel clinical and statistical development strategies. His versatile publication record comprises more than 250 contributions ranging from computational chemistry to clinical oncology.
The editors are past and current chairs of the Drug Information Association Adaptive Design Scientific Working Group, an international group of over 200 statisticians focused on novel clinical study designs and their role in bringing new medicines to patients.
- 2018, 1. Auflage, 322 Seiten, Englisch
- Herausgegeben: Zoran Antonijevic, Robert A. Beckman
- Verlag: Taylor & Francis
- ISBN-10: 1351683934
- ISBN-13: 9781351683937
- Erscheinungsdatum: 07.12.2018
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
- Dateiformat: PDF
- Größe: 5.08 MB
- Mit Kopierschutz
- Vorlesefunktion
Schreiben Sie einen Kommentar zu "Platform Trial Designs in Drug Development".
Kommentar verfassen